S'abonner

The Prognostic Value of Right Atrial Strain Imaging in Patients with Precapillary Pulmonary Hypertension - 03/08/21

Doi : 10.1016/j.echo.2021.03.007 
Nina E. Hasselberg, MD, PhD a, b, Nobuyuki Kagiyama, MD, PhD a, c, Yuko Soyama, MD, PhD c, Masataka Sugahara, MD a, Akiko Goda, MD, PhD a, Keiko Ryo-Koriyama, MD, PhD a, Omar Batel, MD a, Murali Chakinala, MD c, Marc A. Simon, MD a, John Gorcsan, MD, FASE c, d,
a Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 
b Department of Cardiology and Center for Cardiological Innovation, Oslo University Hospital, Oslo, Norway 
c Division of Cardiology, Washington University in St. Louis, St. Louis, Missouri 
d Penn State University College of Medicine, Hershey Medical Center, Hershey, Pennsylvania 

Reprint requests: John Gorcsan III, MD, FASE, Penn State University College of Medicine, Hershey Medical Center, 500 University Drive, Mail Code H047, Hershey, PA 17033.Penn State University College of MedicineHershey Medical Center500 University DriveMail Code H047HersheyPA17033

Abstract

Background

Right ventricular (RV) failure in patients with pulmonary hypertension (PH) is associated with unfavorable clinical events and a poor prognosis. Elevation of right atrial (RA) pressure is established as a marker for RV failure. However, the additive prognostic value of RA mechanical function is unclear.

Methods

The authors tested the hypothesis that RA function by strain echocardiography has prognostic usefulness by studying 165 consecutive patients with precapillary PH defined invasively: mean pulmonary artery pressure ≥ 25 mm Hg and pulmonary capillary wedge pressure < 15 mm Hg. Speckle-tracking strain analyses of the right atrium and right ventricle were performed, along with routine measures. Peak RA strain values from six segments using generic speckle-tracking software were averaged to RA peak longitudinal strain, representing RA global reservoir function. The primary end point was all-cause mortality during 5 years of follow-up. RA strain was similarly analyzed in a control group of 16 normal subjects for comparison.

Results

There were 151 patients with PH (mean age, 55 ± 16 years; 73% women; mean World Health Organization functional class, 2.6 ± 0.6), after 14 exclusions (three with atrial septal defects and 11 with left ventricular ejection fractions < 50%). RA strain measurement was feasible in 93% of patients and RV strain measurement in 88%. RA peak longitudinal strain was significantly reduced in patients with PH compared with control subjects, as expected (P < .001). During 5-year follow-up, 73 patients (48%) died. Patients with RA peak strain in the lowest quartile (<25%) had a significant risk for death (P = .006), even after correcting for confounding variables. RA strain was independently associated with survival in multivariate analysis (P = .039) and had additive prognostic value to RV strain (log-rank P = .01) in subgroup analysis.

Conclusions

RA peak longitudinal strain had additive prognostic usefulness to other clinical measures, including RV strain, RA area, and RA pressure, in patients with PH. RA mechanical function by strain imaging has potential for clinical applications in patients with PH.

Le texte complet de cet article est disponible en PDF.

Graphical abstract

Graphical Abstract Prognostic value of RA strain in patients with PH. Left panels show two examples RA strain from patients with PH. Top left shows a survivor with RA peak strain of 49%; bottom left shows a nonsurvivor with peak RA strain of 22%. Right panel shows Kaplan-Meier plots of patients with PH grouped by RA strain above and below 25%, demonstrating a significant association with survival.



Le texte complet de cet article est disponible en PDF.

Highlights

Determining prognosis for patients with pulmonary hypertension is important.
RA strain imaging can assess RA mechanical function noninvasively.
RA peak longitudinal strain is associated with survival and is of prognostic importance.
RA strain assessment has promise for clinical utility in pulmonary hypertension.

Le texte complet de cet article est disponible en PDF.

Keywords : Right atrial strain, Right atrial reservoir function, Speckle-tracking echocardiography, Pulmonary hypertension, Prognosis, Mortality

Abbreviations : HR, LV, LVEF, PAP, PH, RA, RV, TAPSE


Plan


 This work was supported by the Research Council of Norway funding the Center for Cardiological Innovation (grant 203489 to Dr. Hasselberg), Oslo, Norway.
 Conflicts of interest: Dr. Gorcsan has received research grant support from GE Medical Systems, Norway; Cannon, Japan; EBR Systems, United States and V-Wave, United States. Dr. Simon has received research funding from Aires Pharmaceuticals, United States.


© 2021  American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 34 - N° 8

P. 851 - août 2021 Retour au numéro
Article précédent Article précédent
  • Novel Echocardiographic Algorithm for Right Ventricular Mass Quantification: Cardiovascular Magnetic Resonance and Clinical Prognosis Validation
  • Jonathan Kochav, Jennifer Chen, Lakshmi Nambiar, Hannah W. Mitlak, Arielle Kushman, Razia Sultana, Evelyn Horn, Arindam RoyChoudhury, Richard B. Devereux, Jonathan W. Weinsaft, Jiwon Kim
| Article suivant Article suivant
  • Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019
  • Yamuna Sanil, Amrit Misra, Raya Safa, Jennifer M. Blake, Ahmad Charaf Eddine, Preetha Balakrishnan, Richard U. Garcia, Rachel Taylor, John N. Dentel, Jocelyn Ang, Katherine Cashen, Sabrina M. Heidemann, Christian Bauerfield, Usha Sethuraman, Ahmad Farooqi, Sanjeev Aggarwal, Gautam Singh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.